Cannabis-related disorders, hospitalization, and cardiovascular outcomes in patients with heart failure: A real-world propensity-matched cohort study

BACKGROUND: The clinical implications of cannabis exposure in patients with heart failure remain uncertain. We evaluated the associations between a documented cannabis-related disorder (CRD) and hospitalization and cardiovascular outcomes in a large real-world heart failure cohort. METHODS: We performed a retrospective cohort study using the TriNetX US Collaborative Network. Adult patients with heart failure (ICD-10-CM I50) were identified and stratified by the presence or absence of cannabis-related disorder (ICD-10-CM F12) recorded within 1 year on or before the first heart failure diagnosis, which served as the index date. The primary outcome was all-cause hospitalization at 1 year. Secondary outcomes included stroke, myocardial infarction, end-stage renal disease, atrial fibrillation/flutter, and all-cause mortality. Follow-up began 1 day after the index date; patients with a prior history of a given outcome were excluded from that analysis. One-to-one propensity score matching was performed using 26 baseline covariates. RESULTS: After matching, 30,624 patients were included in each cohort. At 1 year, a documented CRD was associated with a higher risk of hospitalization (57.5% vs. 45.1%; HR, 1.468; 95% CI, 1.436-1.501; p < 0.001). A documented CRD was also associated with significantly higher all-cause mortality (10.4% vs 9.3%; HR, 1.147; 95% CI, 1.090-1.207; p < 0.001), stroke (2.9% vs 2.3%; HR, 1.263; 95% CI, 1.138-1.401; p < 0.001), and myocardial infarction (6.0% vs 4.4%; HR, 1.415; 95% CI, 1.307-1.531; p < 0.001). Atrial fibrillation/flutter and end-stage renal disease did not differ. The hospitalization association persisted after excluding the first 30 days of follow-up (HR 1.252; 95% CI 1.226-1.280; p < 0.001), was similar in women and men, and remained in multivariable Cox models (adjusted HR 1.521; 95% CI 1.503-1.539; p < 0.001). CONCLUSIONS: In this real-world propensity score-matched cohort of patients with heart failure, a documented cannabis-related disorder was associated with higher risks of hospitalization and selected adverse cardiovascular outcomes. Prospective studies with precise cannabis exposure characterization are needed to confirm these associations.

Authors

Institutions

Publication Details

Journal
Clinical Research in Cardiology
Published
2026-11-18
DOI
https://doi.org/10.1007/s00392-026-03056-5
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cannabis-related disorders, hospitalization, and cardiovascular outcomes in patients with heart failure: A real-world propensity-matched cohort study

Aabha Divya, Mrudula R. Munagala, Sapna Desai, Heeran S. Karim et al.
4 links
Clinical Research in Cardiology
Heart Failure Treatment and Management
article

Cannabis-related disorders, hospitalization, and cardiovascular outcomes in patients with heart failure: A real-world propensity-matched cohort study

Aabha Divya, Mrudula R. Munagala, Sapna Desai, Heeran S. Karim, Ruben J. Azocar, Niti Dalal, Dani S. Bengoa, Mark Sanadi
article en

Abstract

BACKGROUND: The clinical implications of cannabis exposure in patients with heart failure remain uncertain. We evaluated the associations between a documented cannabis-related disorder (CRD) and hospitalization and cardiovascular outcomes in a large real-world heart failure cohort. METHODS: We performed a retrospective cohort study using the TriNetX US Collaborative Network. Adult patients with heart failure (ICD-10-CM I50) were identified and stratified by the presence or absence of cannabis-related disorder (ICD-10-CM F12) recorded within 1 year on or before the first heart failure diagnosis, which served as the index date. The primary outcome was all-cause hospitalization at 1 year. Secondary outcomes included stroke, myocardial infarction, end-stage renal disease, atrial fibrillation/flutter, and all-cause mortality. Follow-up began 1 day after the index date; patients with a prior history of a given outcome were excluded from that analysis. One-to-one propensity score matching was performed using 26 baseline covariates. RESULTS: After matching, 30,624 patients were included in each cohort. At 1 year, a documented CRD was associated with a higher risk of hospitalization (57.5% vs. 45.1%; HR, 1.468; 95% CI, 1.436-1.501; p < 0.001). A documented CRD was also associated with significantly higher all-cause mortality (10.4% vs 9.3%; HR, 1.147; 95% CI, 1.090-1.207; p < 0.001), stroke (2.9% vs 2.3%; HR, 1.263; 95% CI, 1.138-1.401; p < 0.001), and myocardial infarction (6.0% vs 4.4%; HR, 1.415; 95% CI, 1.307-1.531; p < 0.001). Atrial fibrillation/flutter and end-stage renal disease did not differ. The hospitalization association persisted after excluding the first 30 days of follow-up (HR 1.252; 95% CI 1.226-1.280; p < 0.001), was similar in women and men, and remained in multivariable Cox models (adjusted HR 1.521; 95% CI 1.503-1.539; p < 0.001). CONCLUSIONS: In this real-world propensity score-matched cohort of patients with heart failure, a documented cannabis-related disorder was associated with higher risks of hospitalization and selected adverse cardiovascular outcomes. Prospective studies with precise cannabis exposure characterization are needed to confirm these associations.

Clinical Research in Cardiology
Tulane University (US), University of Miami (US)
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon